A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 6 relevant products
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 4 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
Hangzhou Biotest Biotech Co., Ltd
China · 2 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
Shanghai i-Reader biotech Co.,Ltd
China · 1 relevant product
AEHEALTH Limited
China · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Shenzhen Homed Medical Device Co., Ltd.
China · 2 relevant products
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 118 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.
Lumigenex (Suzhou) Co., Ltd · China
A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic reagent kit for detecting cardiac troponin I, myoglobin, and creatine kinase-MB using microfluidic immunofluorescence method. This multiplex test is used for acute myocardial infarction diagnosis.
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
A diagnostic test kit for simultaneously detecting cardiac troponin I, myoglobin, and creatine kinase-MB using microfluidic immunofluorescence method. This kit is used for clinical laboratory testing to measure multiple cardiac markers in patient samples.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.
Hangzhou Biotest Biotech Co., Ltd · China
A rapid immunochromatographic assay using colloidal gold-labeled fixed-phase technology to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, or plasma. The triple simultaneous detection provides greater clinical diagnostic significance for cardiac assessment.
Rayto Life and Analytical Sciences Co., Ltd. · China
Cardiac biomarker assay for detection of myocardial infarction and acute coronary syndrome. Supports rapid cardiac risk stratification in emergency settings.
Shanghai i-Reader biotech Co.,Ltd · China
Cardiac Troponin I (cTnI) test kit for rapid quantitative detection of cardiac troponin I in serum or plasma samples. Used for diagnosis and risk stratification of acute myocardial infarction and acute coronary syndromes in clinical laboratory and point-of-care settings. Supports timely cardiac assessment and patient management.
AEHEALTH Limited · China
Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.
BEACON DIAGNOSTICS PVT. LTD. · India
Cardiac biomarker test kit for rapid detection of myocardial infarction. High-sensitivity assay for cardiac troponin in blood samples.
Shenzhen Homed Medical Device Co., Ltd. · China
A diagnostic test kit for measuring cardiac troponin I levels. Used for myocardial infarction detection and cardiac injury assessment.
106 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products